PubMed Health⌕ Search

PubMed · 3600249

Even-echo rephasing and constant velocity flow.

Abstract

It has been shown previously that for constant magnetic field gradients, constant velocity flow leads to even-echo rephasing for all echo delay times. We show that for flow which is not pluglike, even-echo rephasing also occurs for the pulsed readout gradients used in magnetic resonance imaging if and only if the gradients begin at the time the 90 degrees pulse is applied. We also show for these gradients that even-echo rephasing for all echo delay times in the case of nonpluglike flow implies a constant flow velocity at the point considered. Furthermore, it suffices to assume the vanishing of the spin-echo phase for any even echo, since the vanishing of any even echo for all echo delay times implies that all other even echoes also vanish identically. The odd echoes are then all equal to each other and proportional to the flow velocity. If acceleration is present, it may then be seen that for nonpluglike flow, even-echo rephasing may only be present for some but not all echo delay times. However, for the typical slice selection gradients used in magnetic resonance imaging or for usual readout gradients starting after the 90 degrees pulse is applied, it is shown that for constant velocity flow the even-echo phases do not vanish identically. Hence, rephasing cannot always occur for nonpluglike flow in either of these situations. Furthermore, the spin-echo phases are proportional to the flow velocity.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Katz, R M Peshock, C R Malloy, S Schaefer, R W Parkey. 1987. Even-echo rephasing and constant velocity flow.. https://doi.org/10.1002/mrm.1910040503

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗